A trained oncology surgeon/tumor immunologist with 25+ year cancer immunotherapy research/clinical experience and a deep understanding of industry early/late clinical drug development as well as a pioneer in immune checkpoint blockade immunotherapy translational biomarker research to potentially identify right treatment for right patient in different disease settings. (Worked with Drs. Lloyd Old and James Allison from 2002-2016 as Director of Immune Monitoring at MSKCC; Lead translational oncology studies, translational biomarker diagnosis and AI teams since 2016 at Merck; Chair of SITC Biomarker Task Force, TMB subcommittee and CAHON Industry committee.)